Cladophialophora: Difference between revisions
From IDWiki
Cladophialophora
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
m (Aidan moved page Cladophialophora species to Cladophialophora without leaving a redirect: Text replacement - " species$" to "") |
(No difference)
|
Revision as of 20:51, 27 January 2022
- Includes Cladophialophora bantiana and Cladophialophora modesta, which are neurotropic and cause CNS disease
- Other Cladophialophora species may cause mild cutaneous lesions to disseminated disease.
Background
Microbiology
- Cladophialophora bantiana and Cladophialophora modesta, which cause fungal brain abscesses
- Cladophialophora arxii, Cladophialophora emmonsii, and Cladophialophora modesta can cause brain abscess as well as non-CNS disease
- Cladophialophora carionii causes chromoblastomycosis
- Many non-pathogenic species, which can be laboratory contaminants
Epidemiology
- More common in India
- Associated with soil, bark, or carbon-rich environments, like coal mining or sawdust
- More common in gardeners and farmers, but not exclusive
- Unclear if acquired by inhalation or implantation
Clinical Manifestations
- Certain species may present as fungal brain abscess
Diagnosis
- Culture
- Microscopy
- Long, delicate, branching chains of hydrophobic brown conidia and lacking yeast cells, with brown septate hyphae
- The species (and Cladosporium) are differentiated by physiologic tests include temperature tolerance, gelatin liquefaction, cycloheximide growth, urease test, and the nitrate test
- Microscopy
- Histopathology is necessary for subcutaneous infections
Management
- Surgical resection is recommended when possible
- CNS disease may not respond to antifungal therapy
- Amphotericin B, flucytosine, caspofungin and terbinafine, or an extended spectrum triazole may be tried when surgical resection is not possible
- For Cladophialophora bantiana infections, the combination of the three drugs (flucytosine, micafungin and posaconazole) is recommended based on a mouse model1
- Isavuconazole has very promising responses in CNS infections, though limited data2
References
- ^ Marçal Mariné, F. Javier Pastor, Josep Guarro. Combined antifungal therapy in a murine model of disseminated infection byCladophialophora bantiana. Medical Mycology. 2009;47(1):45-49. doi:10.1080/13693780802526840.
- ^ Stefan Schwartz, Oliver A Cornely, Kamal Hamed, Francisco M Marty, Johan Maertens, Galia Rahav, Raoul Herbrecht, Werner J Heinz. Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system. Medical Mycology. 2019. doi:10.1093/mmy/myz103.